FABP4 and atherosclerosis: However, recent studies have shown that FABP4 is released from adipocytes [13], [14], [27] and that serum concentration of FABP4 is associated with obesity, insulin resistance, diabetes, hypertension, cardiac dysfunction, atherosclerosis and inflammatory markers [14]–[20], [28].